Citation Impact
Citing Papers
Molecular Mechanisms of RET Receptor–Mediated Oncogenesis in Multiple Endocrine Neoplasia 2B
2006
High Penetrance of Pheochromocytoma Associated with the Novel C634Y/Y791F Double Germline Mutation in the RET Protooncogene
2010
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Genotype-phenotype correlation in multiple endocrine neoplasia type 2
2012
Cancer treatment and survivorship statistics, 2022
2022 Standout
V804M RET mutation and familial medullary thyroid carcinoma: Report of a large family with expression of the disease only in the homozygous gene carriers
2002
Genotype-phenotype correlations in Hungarian patients with hereditary medullary thyroid cancer
2006
Guidelines for radioiodine therapy of differentiated thyroid cancer
2008
Italian consensus for the classification and reporting of thyroid cytology
2014 Standout
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Peak Incidence of Pheochromocytoma and Primary Hyperparathyroidism in Multiple Endocrine Neoplasia 2: Need for Age-Adjusted Biochemical Screening
2013
Thyroid cancer
2016 Standout
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
2013
Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene
2008
The Genetic Basis of Pheochromocytoma
2003
EANM procedure guidelines for therapy of benign thyroid disease
2010
A Two-Hit Model for Development of Multiple Endocrine Neoplasia Type 2B by RET Mutations
2000
Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto‐oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal
2006
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype
2006
Advances in the management of hereditary medullary thyroid cancer
2004
Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?
2003
Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives
2015
When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
2003
RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?
2002
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study
2001
A Novel Point Mutation of theRETProtooncogene Involving the Second Intracellular Tyrosine Kinase Domain in a Family with Medullary Thyroid Carcinoma
2004
Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: an analysis of 41 cases investigated in a single endocrine centre
2004
Codon-Specific Development of Pheochromocytoma in Multiple Endocrine Neoplasia Type 2
2005
Hereditary medullary thyroid cancer in Slovenia – genotype-phenotype correlations
2006
A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening
2006
Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791*
2008
Multiple endocrine neoplasia type 2 andRET: from neoplasia to neurogenesis
2000
Very early detection of RET proto‐oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children
2002
Early Malignant Progression of Hereditary Medullary Thyroid Cancer
2003
Lithium and thyroid
2009
Multiple endocrine neoplasia type 2 and the RET protooncogene: From bedside to bench to bedside
2005
Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene
2003
The RET Mutation E768D Confers a Late-onset Familial Medullary Thyroid Carcinoma – Only Phenotype with Incomplete Penetrance: Implications for Screening and Management of Carrier Status
2006
Familial Medullary Thyroid Carcinoma with Noncysteine RET Mutations: Phenotype-Genotype Relationship in a Large Series of Patients
2001
Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre
2006
Exon 5 of the RET proto-oncogene: A newly detected risk exon for familial medullary thyroid carcinoma, a novel germ-line mutation Gly321Arg
2005
Genotype-Phenotype Correlations in Hereditary Medullary Thyroid Carcinoma: Oncological Features and Biochemical Properties1
2001
Multiple Endocrine Neoplasia Type 2
2003
Multiple endocrine neoplasia type 2 RET protooncogene database: Repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations
2009
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Primary Hyperparathyroidism as the Leading Symptom in a Patient with a Y791F RET Mutation
2005
Frequency of RET Proto-Oncogene Mutations in Patients with Normal and with Moderately Elevated Pentagastrin-Stimulated Serum Concentrations of Calcitonin
2004
Penetrance and Clinical Manifestations of Non-Hotspot Germline RET Mutation, C630R, in a Family with Medullary Thyroid Carcinoma
2005
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
A Rare Extracellular D631Y Germl ine Mutation of the RET Proto-Oncogene in Two Korean Families with Multiple Endocrine Neoplasia 2A
2006
Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype-phenotype correlation: an appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilian families.
2013
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
2006
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Nuklearmedizinische Therapie und Nachsorge des differenzierten Schilddrüsenkarzinoms: Status quo
2010
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
2010 Standout
Genotype‐Phenotype Based Surgical Concept of Hereditary Medullary Thyroid Carcinoma
2007
Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma
2012
A Novel 9-Base Pair Duplication in RET Exon 8 in Familial Medullary Thyroid Carcinoma1
1999
Estimation of Risk of Inherited Medullary Thyroid Carcinoma in Apparent Sporadic Patients
2001
[Medullary thyroid carcinoma: the comparison of the hereditary and sporadic types of cancer].
2007
Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma
2011
Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome
2012
Cancer treatment and survivorship statistics, 2019
2019 Standout
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Codon Y791F Mutations in a Large Kindred: Is Prophylactic Thyroidectomy Always Indicated?
2007
Guidelines for the management of thyroid cancer
2014 Standout
A Novel Mutation (D631del) of the RET Gene Was Associated with MEN2A in a Chinese Pedigree
2009
RET Proto-Oncogene in the Development of Human Cancer
1999
Thyroid carcinoma
2003 Standout
Works of Peter Groth being referenced
A New Hot Spot for Mutations in theretProtooncogene Causing Familial Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2A1
1998
Change in the intrathyroidal kinetics of radioiodine under continued and discontinued antithyroid medication in Graves’ disease
2006
The Use of Thyrogen® in the Treatment of Differentiated Thyroid Carcinoma: An Intraindividual Comparison of Clinical Effects and Implications of Daily Life
2009
Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study
2002
Incidence of radiation-induced Graves? disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay
2004
[Results of TcTUs-optimized radioiodine therapy in multifocal and disseminated autonomy].
1999
Results of a risk adapted and functional radioiodine therapy in Graves’ disease
2005
Lithium as an adjunct to radioiodine therapy in Graves’ disease for prolonging the intrathyroidal effective half-life of radioiodine
2006